Thus, we performed immunostainings against keratins K10—a reliable marker of well differentiated tumors—and K13—a keratin not expressed in normal skin and considered a marker of tumor progression when it is aberrantly expressed in skin tumors [33]. The gene discussed is KRT10; the disease is skin neoplasm.